Pancreatic cancer is a malignant cancer with a high mortality rate. The amount of chymotrypsin C in pancreatic cancer cells is only 20% of that found in normal cells. Chymotrypsin C has been reported to be involved in cancer cell apoptosis, but its effect on pancreatic cancer cell migration is unclear. We performed cell migration scratch assays and Transwell experiments, and found that cell migration ability was downregulated in pancreatic cancer Aspc-1 cells that overexpressed chymotrypsin C, whereas the cell migration ability was upregulated in Aspc-1 cells in which chymotrypsin C was suppressed. Two-dimensional fluorescence differential in gel electrophoresis/mass spectrometry method was used to identify the proteins that were differentially expressed in Aspc-1 cells that were transfected with plasmids to induce either overexpression or suppressed expression of chymotrypsin C. Among 26 identified differential proteins, cytokeratin 18 was most obviously correlated with chymotrypsin C expression. Cytokeratin 18 is expressed in developmental tissues in early stages of cancer, and is highly expressed in most carcinomas. We speculated that chymotrypsin C might regulate pancreatic cancer cell migration in relation to cytokeratin 18 expression.
Introduction
Chymotrypsin C (EC 3.4.21.2) is a member of the serine endopeptidase chymotrypsin family, which is secreted in the pancreas. It is composed of 252 amino acids with 5 pairs of disulfide bonds and the catalytic triad (catalytic center) is composed of three amino acids: Ser, His, and Asp, which is also found in other serine proteases. Chymotrypsinogen C is activated by trypsin and cleaved into one small and one large peptide fragment linked with a disulfide bond [1] . Chymotrypsin C is quite different from other members of the family in terms of activity, stability, and amino acid sequences. Its structure is rather similar to that of the members of the elastase family. In vitro, chymotrypsin C preferentially cleaves the peptide bonds formed of the C terminal of Tyr, Met, and Leu residues [2, 3] ; and in vivo, it specifically cleaves the Leu81-Glu82 bond in the calciumbinding loop of trypsin at low calcium concentrations, which leads to regulation of trypsin inactivation [4] . In the pancreas, the concentration of chymotrypsin C is almost equivalent to that of kallikrein, a serine protease that plays an important role in regulating cardiovascular functions. Their concentrations are rather lower than those of other digestive enzymes: about 5% of trypsin, chymotrypsin A and B. It is presumed that, like kallikrein, chymotrypsin C might not function primarily as a digestive enzyme, but it probably played other physiological roles. Chymotrypsin C has been reported to regulate and decrease the calcium ion level in blood [5] ; consequently, it is also called caldecrin. Alternative names for chymotrypsin C are caldecrin, enzyme Y, granzyme M, and elastase-associated acidic endopeptidase, all of which have been verified to be the same enzyme, namely, chymotrypsin C (from Braunsch-weig Enzyme Database).
In pancreatic cancer, chymotrypsin C expression drastically decreases by around 80% soon after the onset (from human gene compendium). Recently, it has been reported that patients with inherited chronic pancreatitis who have chymotrypsin C mutants with low or no activity tend to develop pancreatic cancer [6] . Pancreatic cancer is a malignant tumor with no symptoms in the early stages, and there is no effective method for early diagnosis. It is very invasive, and even at the onset of cancer development, and so cancer cells can be detected in blood and lymph [7] . Thus, these cancer cells can invade most tissues. Once pancreatic cancer is diagnosed, the average survival of patients is only about 3-6 months. If the cancer is operable, the 5-year survival rate is less than 5%, and complete remission is rare. The relationship between chymotrypsin C and pancreatic cancer metastasis is unclear to date.
To explore the function of chymotrypsin C in pancreatic cancer cells, Aspc-1 cells transfected with plasmids that induce either overexpression or suppressed expression of chymotrypsin C were used to investigate the effects on cancer cell motility. Using two-dimensional fluorescence differential in gel electrophoresis/mass spectrometry (2D-DIGE/MS) methods, 26 proteins in response to altered expression of chymotrypsin C were identified. Among these proteins, cytokeratin 18 was best correlated with the expression of chymotrypsin C. The results provide a better understanding of the effects of chymotrypsin C and its related proteins in pancreatic cancer migration.
Materials and Methods
Construction of plasmid for overexpression of chymotrypsin C The human pancreas cDNA library was used as a template to amplify the full-length cDNA of chymotrypsin C with primer pairs P1 (5 0 -ATGTTGGGCATCACTGTCCTC-3 0 ) and P1 0 (5 0 -CAGCTGCATTTTCTCGTTGAT-3 0 ). The fulllength human chymotrypsin C cDNA was subcloned into the plasmid pEGFP-N3 with EcoR1 and BglII sites. The recombinant plasmid was named as pEGFP-ChT.
Construction of shRNAs targeting the chymotrypsin C gene Three short-hairpin RNAs (shRNAs) and a control were synthesized by Invitrogen (Carlsbad, USA) and subcloned into the pSUPER plasmid with HindIII and BglII. The sequences of the RNAi molecules are shown in Table 1 .
Cell culture and plasmids transfection
The human pancreatic cancer cell line Aspc-1 was cultured in RPMI 1640 medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS) in 10-cm plates at 378C with 5% CO 2 . Transient transfection was performed with Fugene HD (Roche, Penzberg, Germany) according to the manufacturer's instructions. The Aspc-1 cells were transfected with pEGFP-ChT, pSUPER-RNAiC, pSUPERRNAi1#, pSUPER-RNAi2#, and pSUPER-RNAi3# vectors, respectively. After transfection, the cells were further cultured for 48 h.
Cell lysate preparation and immunoblotting
The cultured cells were lysed in lysis buffer (10 mM Tris, pH 7.4, 1 mM EDTA, 0.5 mM EGTA, 150 mM NaCl, 1% Triton X-100, 50 mM NaF, 10 mM Na 4 P 2 O 7 . 10H 2 O, 5 mg/L aprotinin, 5 mg/L leupeptin, and 1 mM PMSF). Approximately 50 mg of proteins was removed from the supernatant and used for SDS-PAGE electrophoresis on a 12.5% gel, and then transferred onto a nitrocellulose membrane (Hybond; Amersham, Buckinghamshire, UK). After being blocked with 5% skimmed milk powder in the Tris-buffered saline containing 0.1% Tween-20 (TBST), the membrane was incubated with appropriate primary antibodies (CTRC purified MaxPab mouse polyclonal antibody, 1:2000; Abnova, Heidelberg, Germany). Then the membrane was washed with TBST, and incubated with the HRP-conjugated secondary antibody (anti-mouse IgG, HRP-conjugated antibody, 1:1000; Cell Signaling, Danvers, USA). The immunoreactive bands were detected by enhanced chemiluminescent reagent (Amersham).
Quantitative real-time PCR Total RNA was extracted with Trizol reagent (Invitrogen) and reverse transcribed using ImProm II TM reverse transcription system (Promega, Madison, USA) according to manufacturer's protocols. Synthesized cDNA (1 ml) was used in a 20-ml reaction volume containing 10 ml of Power SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK). Results were derived from the comparative threshold cycle method, and normalized by b-actin as an internal control. The following primers were used for GATCCCCGCAATGATATTGCCCTCATTTCAAGAGAATGAGGGCAATATCATTGCTTTTTAAGCT TAAAAAGCAATGATATTGCCCTCATTCTCTTGAAATGAGGGCAATATCATTGCGGG real-time PCR: cytokeratin 18:
Cell migration assessed by the scratch assay After transfection with the recombinant vector pEGFP-ChT or pSUPER-RNAi3#, the normally growing and transfected Aspc-1 cells were seeded into six-well plates and cultured in RPMI 1640 medium supplemented with 10% FBS at 378C with 5% CO 2 . On the next day, when cells grew to about 80% confluency, a scratch about 0.6 mm wide was marked on the confluent Aspc-1 cell monolayer using a 20-ml micropipette tip. Then the cells were washed with phosphate-buffered saline (PBS) for three times and further cultured in RPMI 1640 medium. The cell migration over the scratch was monitored by photographing at 0 and 20 h with a 10Â objective lens. The average scratch width was calculated at five random points.
Cell migration assessed by Transwell assays
Matrigel (BD Pharmingen, Franklin Lakes, USA) was thawed on ice in 48C refrigerator overnight and diluted with serum-free medium at a ratio of 1:7. Then the Transwell chambers (diameter 6.5 mm, pore 8 nm; Corning, New York, USA) were coated with 50 ml of diluted matrigel in a 24-well plate, and placed into the incubator for 3 h. The normally growing Aspc-1 cells and the cells transfected with pEGFP-ChT and pSUPER-RNAi3# were dispersed by trypsin, then adjusted to 4 Â 10 5 cells/ml with serum-free RPMI 1640 medium, and 200 ml were seeded into the prepared Transwell chambers. Then 500 ml of RPMI 1640 medium with 10% FBS were added to the basal chamber. The 24-well plate was then placed in an incubator at 378C with 5% CO 2 for 24 h. After incubation, the cells remaining on the upper chamber were carefully removed, and the Transwell membrane was fixed with dehydrated alcohol and stained with hematoxylin. Photographs were taken to count the fixed cells randomly from 10 fields of vision with 20 Â magnification. Independent experiments were performed in triplicate.
Cell lysate for 2D-DIGE When non-transfected and transfected cells numbered 10 7 , they were washed for three times in 100 mM PBS. Each cell pellet was resuspended in 200 ml of lysis buffer (6 M urea, 2 M thiourea, 4% 3-[(3-cholamidopropyl) dimethylammonio]propanesulfonate, and 30 mM Tris, pH 8.8), then transferred into an eppendorf tube. The cells were further lysed by ultrasonication (80 W for 10 s at 10 s intervals, repeated 10 times). The supernatants were collected after centrifugation at 12,000 g for 40 min. Salt and contaminants were removed using a 2D cleanup kit (Bio-Rad, Hercules, USA). The protein concentration was measured using the Bradford method (Bio-Rad) and adjusted to 5 mg/ml.
2D fluorescence differential in gel electrophoresis
An equal amount of each lysate of the normally growing, pEGFP-ChT-and pSUPER-RNAi3#-transfected Aspc-1 cells were mixed together and labeled with green dye Cy2 as an internal standard. Lysate proteins (50 mg) of nontransfected, pEGFP-ChT-transfected, and pSUPER-RNAi3-#-transfected cells were labeled with 400 pmol of blue dye Cy3 or red dye Cy5. The samples were then incubated on ice for 40 min in the dark. The labeling reaction was terminated by adding 1 ml of 10 mM lysine. For 2D-DIGE analysis, 50 mg of Cy2-, Cy3-, and Cy5-labeled proteins were mixed together, and used for isoelectric focusing. Immobiline DryStrips (GE Healthcare, Wisconsin, USA; pH 3210, 13 cm) were used under the following running conditions: rehydration for 12 h at 30 V, step and hold at 500 V, 1000 V for 1 h each, and then at 8000 V until reaching a total volt-hour of 40,000 Vh. Then 12.5% SDS-PAGE was performed at 15 mA for 20 min and then at 25 mA until the bromphenol blue front reached the end of the gel.
Image capture and analysis Using Typhoon Variable Mode Imager 9400 (GE Healthcare), the Cy2-, Cy3-, and Cy5-labeled protein images were obtained by excitation at 488, 532, and 633 nm, and recording emissions at 520, 590, and 680 nm, respectively. The DIGE images were analyzed using the DeCyder 6.5 software (GE Healthcare). Spot detection was performed using the differential in-gel analysis module with an estimated number of 2500 spots. After removing the artificial spots by manual editing, DIGE images were further analyzed using the DeCyder BVA (biological variation analysis) module. For each image treatment, at least three biological repeats were used for statistical analysis of the differential proteins.
In-gel digestion and matrix assisted laser desorption ionization -time of flight mass spectrometry analysis The spots of interest were excised from gels. After being washed and desalted with 25 mM ammonium bicarbonate containing 50% acetonitrile, the gel samples were dried completely by centrifugal lyophilization, reduced with DTT (10 mM in 25 mM NH 4 HCO 3 ) at 568C for 1 h, and then alkylated with iodoacetamide (55 mM in 25 mM NH 4 HCO 3 ) at room temperature for 45 min. The gel pieces were again vacuum dried, and rehydrated in 8 ml of digestion buffer (10 ng/ml trypsin in 25 mM NH 4 HCO 3 ). After overnight digestion at 378C, the peptides were extracted twice with 50% acetonitrile solution containing 0.1% trifluoroacetic acid. The extracted digests were vacuum dried.
All mass spectra were acquired on a 4800 Proteomics Analyzer matrix assisted laser desorption ionization -time of flight (MALDI-TOF)/TOF-MS (Applied Biosystems). The instrument was operated at an accelerating voltage of 20 kV. A 200-Hz pulsed ND:YAG laser (355 nm) was used for MALDI. The MS instrument was calibrated by 4700 proteomics analyzer calibration mixture (Applied Biosystems) with known molecular masses. The peptides were analyzed in reflector TOF detection mode. The 10 strongest peaks in each mass spectrum were automatically selected for MS/MS analysis. The GPS Explorer software (version 3.6; Applied Biosystems) with Mascot (version 2.1; Matrix Science, London, UK) as a search engine was used to identify proteins against the NCBI_Human_3.07 database. All differential proteins were identified using the peptide fingerprint mass spectra combined with tandem mass spectra. The searching parameters were set up as follows: the enzyme was trypsin, the number of missed cleavages was allowed up to 1, the variable modification was oxidation of methionine, the peptide mass tolerance was 150 ppm, and the tandem mass tolerance was 0.3 Da. Protein scores CI% greater than 95% were considered significant. 
Results and Discussion
Effects of chymotrypsin C on the motility of pancreatic cancer cells Western blotting analysis confirmed that the expression of chymotrypsin C dramatically increased in the pEGFP-ChT-transfected cells (Fig. 1, Lane 1) and significantly decreased in the pSUPER-RNAi3#-transfected cells, compared with the expression in the normally growing Aspc-1 cells. To determine the relationship between chymotrypsin C expression and pancreatic cancer cell motility, the cell migration scratch assay and Transwell experiments were performed. The width of each cell scratch was originally 0.6 mm. After cells were cultured for 20 h, the average width changed to 0.34 mm in the pEGFP-ChT-transfected cells, 0.3 mm in the normally growing cells, and 0.23 mm in the pSUPER-RNAi3#-transfected cells, respectively (Fig. 2) . This result suggested that the expression of chymotrypsin C affected the migration of Aspc-1 cells: less expression resulted in faster migration and vice versa. Similar results were obtained in the Transwell experiments: the migration rate decreased 22% in cells in which chymotrypsin C was overexpressed, and increased 27% in cells with suppressed expression (Fig. 3) . Together, these results show that the expression level of chymotrypsin C has an effect on the migration of pancreatic cancer cells.
Chymotrypsin C and related proteins involved in the Aspc-1 cell migration
To further investigate the effects of chymotrypsin C on pancreatic cancer cell migration, the 2D-DIGE/MS method was used to identify the expression of related proteins that might be involved in cell migration. Using the BVA mode of the Decyder v6.5 software, 1700 protein spots were detected [ Fig. 4(B) ]. Among them, 26 spots that had differential abundance were identified by MS ( Table 2 ; P , 0.05). Four identified proteins (heat shock 70 kDa protein 9 precursor, heat shock 70 kDa protein 8 isoform 1, lamin A/C, and cytokeratin 18) appeared in two or three different spots. This might be because they have different subunits, which are modified at different residues and hydrolyzed into fragments with different isoelectric point Chymotrypsin C and related proteins on pancreatic cancer cell migration values [8] . The 26 proteins were analyzed by gene ontology according to their molecular functions. Among these proteins, structural constituents of the cytoskeleton accounted for 18.1%; actin-binding proteins, for 36.5%; calcium-dependent phospholipid-binding proteins, for 18.1%; and proteins with structural molecule activity, for 27.2% [ Fig. 5(B) ].
To test the reliability of the MS results, lamin A/C was selected to be verified. Compared with the expression level in normally growing Aspc-1 cells, lamin A/C did not change significantly in the pEGFP-ChT-transfected cells, but dramatically decreased in the pSUPER-RNAi3#-transfected cells (Fig. 6) . The results were consistent with the data obtained using 2D-DIGE/MS methods: lamin A/C was downregulated 1.68 folds ( Table 3 ).
Proteins that differentially expressed in response to chymotrypsin C overexpression are listed in Table 3 . Cytokeratin 18 was upregulated 1.23 folds, and annexin A11 was downregulated 1.38 folds. It has been reported that either up-or downregulation of these proteins is related to cancer metastasis [9] [10] [11] . In the case of chymotrypsin C suppression, cytokeratin 18, keratin 19, and prolyl 4-hydroxylase were upregulated 1.31, 1.28, and 1.55 folds, respectively, whereas lamin A/C and heat shock 70 kDa protein 8 were downregulated to about 60 or 79%, respectively. All of these differentially expressed proteins have been reported to be involved in cancer metastasis [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Although the above proteins are all associated with cancer, they (with the exception of cytokeratin 18) had no close correlation with either upregulation or suppression of chymotrypsin C. The changes at protein levels of cytokeratin 18 were also consistent with its mRNA level, which was verified by quantitative RT-PCR. Cytokeratin 18 mRNA and protein levels were related with chymotrypsin C expression as shown in Fig. 7 and Table 3 . However, the mechanism of chymotrypsin C regulating cytokeratin 18 expression is not clear. It is worth pointing out that chymotrypsin C is capable of regulating and decreasing the calcium ion level in blood, even though its protease reactive sites are irreversibly blocked.
Obviously, chymotrypsin C does not function as a protease in the normally growing Aspc-1 cells, but might act on a special target to display its physiological function [5] .
Chymotrypsin C and cytokeratin 18 were correlated in pancreatic cancer Cytokeratin 18 was identified by MS/MS analysis as shown in Fig. 5 (A) (confidence interval .99%). Cytokeratin 18 is a type I intermediate filament protein expressed in developmental tissues at early stages of pancreatic cancer [24] . It is often expressed at elevated levels, although the increase is not higher than 1.4 folds in the pancreatic cancer cells [25] [26] [27] [28] . Cytokeratin 18 often appears in the invasive front of human carcinomas, suggesting that it may be functionally important in tumor cell metastasis [29] . The expression of cytokeratin 18 is dependent on an enhancer element that is located within its first intron, and was capable of binding transcriptional factors [30] . Together, cytokeratin 18 and the enhancer element mediate the activation of the Jun and Fos family members, and consequently activate the Ras signal transduction pathway, which results in uncontrollable proliferation [31] . Thus, the variance of cytokeratin 18 expression is always related to the degree of malignancy [27, [32] [33] [34] , and the regulation of cytokeratin 18 on cell migration has also been reported [35] . As cytokeratin 18 is released into the serum in early stages of carcinoma [36] , it is used as a biomarker for tumor diagnosis.
A recent report has suggested that the elevated level of cytokeratin 18 is associated with malignant transformation in pancreatic cancer cells. The higher the expression of cytokeratin 18, the greater the degree of malignancy in pancreatic cancer cells [28] . Our 2D-DIGE/MS experiments further showed that chymotrypsin C might be associated with the expression of cytokeratin 18; thus, both chymotrypsin C and cytokeratin 18 might be involved in pancreatic cancer migration. The relationship between chymotrypsin family members and pancreatic tumor migration has rarely been studied. The cell migration scratch assay and Transwell test showed that pancreatic cancer cell migration was suppressed when chymotrypsin C was overexpressed. Furthermore, migration was increased when chymotrypsin C was suppressed. Taken together, our results indicated that chymotrypsin C is closely correlated with cytokeratin 18 in malignancy and migration of pancreatic cancer cells.
